Healthcare Providers and Services
Company Overview of Genzyme Polyclonals S.A.S.
Genzyme Polyclonals S.A.S. operates as a subsidiary of Genzyme Corporation.
Les Carrés du Parc
10 rue des Rosiéristes - BP 54
Champagne au Mont D´Or
33 4 37 28 16 00
33 4 37 28 16 79
Key Executives for Genzyme Polyclonals S.A.S.
Chief Executive Officer and Chief Operating Officer
Compensation as of Fiscal Year 2014.
Genzyme Polyclonals S.A.S. Key Developments
Genzyme Presents at Boston CEO Conference, Jun-05-2014 04:00 PM
Jun 2 14
Genzyme Presents at Boston CEO Conference, Jun-05-2014 04:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: David Meeker.
Genzyme Receives Complete Response Letter from Food and Drug Administration on Lemtrada(TM) (alemtuzumab) Application
Dec 30 13
Genzyme announced that it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its supplemental Biologics License Application seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A complete response letter informs companies that an application is not ready for approval. FDA has taken the position that the company has not submitted evidence from adequate and well-controlled studies that demonstrate the benefits of Lemtrada outweigh its serious adverse effects. The company understands that the conclusion is related to the design of the completed Phase 3 active comparator studies of Lemtrada in relapsing-remitting MS patients. FDA has also taken the position that one or more additional active comparator clinical trials of different design and execution are needed prior to the approval of Lemtrada.
Sanofi Announces New Partnership with Genzyme
Sep 19 13
Sanofi and Genzyme announced a new partnership. Genzyme and Sanofi target their philanthropic giving toward areas of need in communities, with particular focus on science and education, including organizations that foster the next generation of diverse STEM leaders. The College of Science and Mathematics has developed a highly successful program for advancing student success in STEM majors. This program revamped advising, academic support, and orientation, and developed a learning community program as the centerpiece of this strategy. Retention in the program is more than 15 points above the college's preexisting levels, with large increases of students remaining in STEM majors.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries